Novo Nordisk has launched legal action accusing Eli Lilly of creating "misleading" ads, a claim its rival denies.
The maker of Wegovy and Ozempic, Novo Nordisk, has launched legal action accusing its arch rival Eli Lilly of false advertising in suggesting its weight-loss drugs perform better. The Danish company